GlassScriptPhysician profile
Brandon Worley
NPI 1457823809
$1,550.33
in general payments reported to CMS, 2019-2025
17 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.33 · 2021: $60.87 · 2022: $139 · 2023: $364 · 2024: $456 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $231.76 | 2023-2025 | Dupixent |
| Leo Pharma INC. | $228.50 | 2020-2025 | Adbry |
| Abbvie INC. | $207.43 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $191.78 | 2022-2025 | |
| Janssen Biotech, INC. | $180.82 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $121.19 | 2021-2024 | Ilumya |
| Pfizer INC. | $99.02 | 2023-2024 | |
| Organogenesis INC. | $54.90 | 2024 | |
| Kerecis Limited | $37.53 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Galderma Laboratories, L.P. | $34.52 | 2025 | Nemluvio |
| Next Science LLC | $29.68 | 2023 | Surgx, Blastx, Xperience |
| Lilly USA, LLC | $25.05 | 2021 | |
| Amgen INC. | $24.71 | 2022 | |
| Acera Surgical, INC. | $24.64 | 2020 | |
| Dermavant Sciences, INC. | $24.08 | 2024 | Vtama |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.32 | 2023 | Sotyktu |
| Nabriva Therapeutics, Plc | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Worley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.